Skip to the page

Data / Drug companies / Viatris Specialty LLC

Viatris Specialty LLC: 79 products in the FDA NDC directory, labeler code 58151

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Viatris Specialty LLC (labeler code 58151) lists 79 products in the FDA National Drug Code Directory, covering 21 finished drugs by generic name. By type: 79 prescription drugs. Its main marketing category is new drug applications (NDA). The newest product started marketing on September 28, 2026.

The request: Watch Viatris Specialty LLC (FDA labeler code 58151): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
58151
Products in commercial distribution
79
Packages
101
Finished drugs by generic name
21
Prescription products
79
Over the counter products
0
Controlled substance products
Schedule IV 6, Schedule V 12
Flagged as original packager
60 of 60 products that carry the flag
Started marketing in the last 12 months
15
Products with a marketing end date set
6
Earliest marketing start
September 12, 2023
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
New drug applications (NDA)7797.5%
Generic drugs (ANDA)22.5%

Products by type

TypeProductsShare
Prescription drugs79100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet, film coated2430.4%
Capsule1924.1%
Tablet1620.3%
Tablet, film coated, extended release56.3%
Capsule, extended release56.3%
Solution22.5%
Tablet, extended release22.5%
Injection, solution11.3%
Suspension11.3%
Solution/ drops11.3%
Solution, concentrate11.3%
Powder, for suspension11.3%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Caduet58151-061Tablet, film coatedNew drug applications (NDA)September 28, 2026
Caduet58151-060Tablet, film coatedNew drug applications (NDA)September 28, 2026
Geodon58151-132CapsuleNew drug applications (NDA)September 16, 2026
Cardura58151-077TabletNew drug applications (NDA)July 15, 2026
Caduet58151-064Tablet, film coatedNew drug applications (NDA)June 24, 2026
Revatio58151-402Tablet, film coatedNew drug applications (NDA)June 22, 2026
Geodon58151-134CapsuleNew drug applications (NDA)April 15, 2026
Neurontin58151-282CapsuleNew drug applications (NDA)April 9, 2026
Caduet58151-067Tablet, film coatedNew drug applications (NDA)February 26, 2026
Caduet58151-066Tablet, film coatedNew drug applications (NDA)February 26, 2026
Caduet58151-065Tablet, film coatedNew drug applications (NDA)February 25, 2026
Caduet58151-063Tablet, film coatedNew drug applications (NDA)February 25, 2026
Caduet58151-062Tablet, film coatedNew drug applications (NDA)February 25, 2026
Neurontin58151-290SolutionNew drug applications (NDA)January 14, 2026
Cardura58151-076TabletNew drug applications (NDA)January 14, 2026
Xanax58151-455TabletNew drug applications (NDA)October 29, 2025
Xanax58151-452TabletNew drug applications (NDA)October 29, 2025
Xanax58151-454TabletNew drug applications (NDA)October 2, 2025
Neurontin58151-284Tablet, film coatedNew drug applications (NDA)October 1, 2025
Neurontin58151-283CapsuleNew drug applications (NDA)October 1, 2025
Neurontin58151-285Tablet, film coatedNew drug applications (NDA)September 19, 2025
Geodon58151-137Injection, powder, lyophilized, for solutionNew drug applications (NDA)September 9, 2025
Geodon58151-133CapsuleNew drug applications (NDA)September 9, 2025
Geodon58151-131CapsuleNew drug applications (NDA)September 9, 2025
Viagra58151-427Tablet, film coatedNew drug applications (NDA)August 5, 2025

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.